Table Info

Table 2.

Systematic review—CPM in a variety of clinical settings

CPM etiology	Reported in
Alcohol and malnutrition	Adams RD (1959) [3] Case report on four malnourished patients
“Any relatively hypertonic insult”	McKee AC (1988) [4] Retrospective study on 3,528 patients submitted to general autopsy
Rapid correction of hyponatremia	Brown WD (2000) [1] Review article
Severe hyperemesis gravidarum-induced hyponatremia	Lee IW (2010) [5] Case report on pregnant woman
Hypophosphatemia	Qadir F (2005) [6] Case report on a young lady with prolonged febrile illness and severe hypophosphatemia
Hypokaliemia	Shintani M (2016) [7] Case report on a 43-year-old diabetic man with nephrotic syndrome
Hypokalemic in nephrogenic diabetes insipidus	Davenport C (2010) [8] Case report on a 63-year-old man with nephrogenic diabetes insipidus
Liver transplantation	Singh N (1994) [9] Clinical review of a subgroup of patients after liver transplantation
Lithium toxicity	Fabisiak DB (2002) [10] Case report on patient in lithium therapy for bipolar disorder
Lymphoma	Doni E (2016) [11] Case report on patient with diffuse large-B cell lymphoma
Acquired metabolic encephalopathies	Sharma P (2009) [12] A pictorially review of the more classic MRI features of several acute toxic and acquired metabolic encephalopathies
Intravenous sodium bicarbonate therapy	Chang KY (2014) [13] Case report on a 40-year-old woman with a bicarbonate deficit
Hyperglycemic with rebound hypernatremia	O’Malley G (2008) [14] Case report on a 49-year-old woman with hyperglycemic hyperosmolar state
Hyperglycemic with normal natremia	Donnelly H (2016) [2] Burns JD (2013) [15] Guerrero WR (2013) [16] Hirosawa (2018) [17] Corps Fernández D (2017) [18] Fasano A (2018) [19] Case reports on patients with hyperglycemia
Binge eating attack induced hyperglycemia in the absent of a relevant hyponatremia	Pliquett RU (2018) [20] Case report on a type 2 diabetes patient with hyperglycemia after a binge-eating attack
Chronic kidney disease	Talluri S (2017) [21] Case report on a patient with chronic kidney disease and hyperosmolar hyperglycemia
Fluctuating hyperglycemia in patient treated with interferon and insulin therapy	Gourine M (2016) [22] Case report on a diabetic young patient chronic hepatitis as predisposing factor for rapid changes in osmolality
Acute hypoglycemia	Madey JJ (2013) [23] Case report in diabetic patient treated with levofloxacin Purucker E (2000) [24] Case report in patient with myocardial infarction following severe hypoglycemia

Declarations

Author contributions

SDA wrote the first draft of the manuscript; SDA and AACC wrote section of the manuscript; SDA, PA, and MM contributed to manuscript revision; all authors read and approved the submitted version.

Conflicts of interest

The authors declare that they have no conflicts of interest.

Ethical approval

Not applicable.

Consent to participate

The consent to participate in the description of the case report is informed.

Consent to publication

Consent to publication of the privacy issues has been obtained.

Availability of data and materials

Not applicable.

Funding

Not applicable.

Copyright

References

Brown WD. Osmotic demyelination disorders: central pontine and extrapontine myelinolysis. Curr Opin Neurol. 2000;13:691–7. [DOI] [PubMed]

Donnelly H, Connor S, Quirk J. Central pontine myelinolysis secondary to hyperglycaemia. Pract Neurol. 2016;16:493–5. [DOI] [PubMed]

Adams RD, Victor M, Mancall EL. Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients. AMA Arch Neurol Psychiatry. 1959;81:154–72. [PubMed]

McKee AC, Winkelman MD, Banker BQ. Central pontine myelinolysis in severely burned patients: relationship to serum hyperosmolality. Neurology. 1988;38:1211–7. [DOI] [PubMed]

Lee IW, Su MT, Kuo PL, Chang CM. Gestational diabetes and central pontine myelinolysis with quadriplegia: a case report. J Matern Fetal Neonatal Med. 2010;23:728–31. [DOI] [PubMed]

Qadir F, Hasan A, Masood M. Extra pontine myelinolysis associated with hypophosphatemia. J Pak Med Assoc. 2005;55:254–6. [PubMed]

Shintani M, Yamashita M, Nakano A, Aotani D, Maeda K, Yamamoto T, et al. Central pontine and extrapontine myelinolysis associated with type 2 diabetic patient with hypokalemia. Diabetes Res Clin Pract. 2005;68:75–80. [DOI] [PubMed]

Davenport C, Liew A, Vic Lau P, Smith D, Thompson CJ, Kearns G, et al. Central pontine myelinolysis secondary to hypokalaemic nephrogenic diabetes insipidus. Ann Clin Biochem. 2010;47:86–9. [DOI] [PubMed]

Singh N, Yu VL, Gayowski T. Central nervous system lesions in adult liver transplant recipients: clinical review with implications for management. Medicine (Baltimore). 1994;73:110–8. [DOI] [PubMed]

10.

Fabisiak DB, Murray GB, Stern TA. Central pontine myelinolysis manifested by temporary blindness: a possible complication of lithium toxicity. Ann Clin Psychiatry. 2002;14:247–51. [DOI] [PubMed]

11.

Doni E, Tremolizzo L, Patassini M, Pioltelli PE, Ferrarese C, Appollonio I. Asymptomatic central pontine myelinolysis without hyponatriemia in diffuse large B cell lymphoma. Neurol Sci. 2016;37:2035–7. [DOI] [PubMed]

12.

Sharma P, Eesa M, Scott JN. Toxic and acquired metabolic encephalopathies: MRI appearance. AJR Am J Roentgenol. 2009;193:879–86. [DOI] [PubMed]

13.

Chang KY, Lee IH, Kim GJ, Cho K, Park HS, Kim HW. Plasma exchange successfully treats central pontine myelinolysis after acute hypernatremia from intravenous sodium bicarbonate therapy. BMC Nephrol. 2014;15:56. [DOI] [PubMed] [PMC]

14.

O’Malley G, Moran C, Draman MS, King T, Smith D, Thompson CJ, et al. Central pontine myelinolysis complicating treatment of the hyperglycaemic hyperosmolar state. Ann Clin Biochem. 2008;45:440–3. [DOI] [PubMed]

15.

Burns JD, Kosa SC, Wijdicks EF. Central pontine myelinolysisina patient with hyperosmolarhyperglycemia and consistently normal serum sodium. Neurocrit Care. 2009;11:251–4. [DOI] [PubMed]

16.

Guerrero WR, Dababneh H, Nadeau SE. Hemiparesis, encephalopathy, and extrapontine osmotic myelinolysis in the setting of hyperosmolar hyperglycemia. J Clin Neurosci. 2013;20:894–6. [DOI] [PubMed]

17.

Hirosawa T, Shimizu T. Osmotic demyelination syndrome due to hyperosmolar hyperglycemia. Cleve Clin J Med. 2008;85:511–3. [DOI] [PubMed]

18.

Corps Fernández D, Terrero Carpio R, Escolar Escamilla E, Pinel González A. Mielinólisis central pontina de curso subagudo secundario a hiperglucemias. Neurología. 2020;35:211–3. [DOI] [PubMed]

19.

Fasano A, Cavallieri F, Mandrioli J, Chiari A, Nichelli P. Central pontine myelinolysis and poorly controlled diabetes: MRI’s hints for pathogenesis. Neurol Sci. 2018;39:193–5. [DOI] [PubMed]

20.

Pliquett RU, Noll A, Ibe R, Katz A, Ackmann C, Schreiber A, et al. Hyperglycemia-related central pontine demyelinization after a binge-eating attack in a patient with type-2 diabetes: a case report. BMC Endocr Disord. 2018;18:18. [DOI] [PubMed] [PMC]

21.

Talluri S, Charumathi R, Khan M, Kissell K. Atypical presentation of central pontine myelinolysis in hyperglycemia. Endocrinol Diabetes Metab Case Rep. 2017;2017:17–0064. [DOI] [PubMed]

22.

Gourine M, Mostefa-Kara A, Saadi S, Arrar M, Cherrak A. Central pontine myelinolysis in a type 1 diabetes patient with chronic hepatitis. Rev Neurol (Paris). 2018;174:66–7. [DOI] [PubMed]

23.

Madey JJ, Hannah JA, Lazaridis C. Central pontine myelinolysis following acute hypoglycemia. Clin Neurol Neurosurg. 2013;115:2299–300. [DOI] [PubMed]

24.

Purucker E, Nguyen HN, Lammert F, Koch A, Matern S. Central pontine myelinolysis and myocardial infarction following severe hypoglycemia. Intensive Care Med. 2000;26:1406–7. [DOI] [PubMed]

25.

Martin RJ. Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes. J Neurol Neurosurg Psychiatry. 2004;75 Suppl 3:iii22–8. [DOI] [PubMed] [PMC]

26.

de Souza A. Movement disorders and the osmotic demyelination syndrome. Parkinsonism Relat Disord. 2013;19:709–16. [DOI] [PubMed]

27.

King JD, Rosner MH. Osmotic demyelination syndrome. Am J Med Sci. 2010;339:561–7. [DOI] [PubMed]

28.

Saini M, Mamauag MJ, Singh R. Central pontine myelinolysis: a rare presentation secondary to hyperglycaemia. Singapore Med J. 2015;56:e71–3. [DOI] [PubMed] [PMC]

29.

Sharma C, Kumawat BL, Panchal M, Shah M. Osmotic demyelination syndrome in type 1 diabetes in the absence of dyselectrolytaemia: an overlooked complication? BMJ Case Rep. 2017;2017:bcr2016219148. [DOI]

30.

Tajitsu M, Yamada T, Cao X, Fukui A, Nagai J, Yambe Y, et al. Osmotic demyelination syndrome complicating diabetes with anti-glutamic acid decarboxylase antibodies and Graves’ disease: a case report. J Diabetes Investig. 2016;7:130–1. [DOI]

31.

Rodríguez-Velver KV, Soto-Garcia AJ, Zapata-Rivera MA, Montes-Villarreal J, Villarreal-Pérez JZ, Rodríguez-Gutiérrez R. Osmotic demyelination syndrome as the initial manifestation of a hyperosmolar hyperglycemic state. Case Rep Neurol Med. 2014;2014:652523. [DOI] [PubMed] [PMC]

32.

Ichikawa H, Murakami H, Katoh H, Hieda S, Kawamura M. Central pontine lesions observed with MRI in four diabetic patients. Intern Med. 2008;47:1425–30. [DOI] [PubMed]